Professional Documents
Culture Documents
Martin S. Eichenbaum
Northwestern University and NBER
Sergio Rebelo
Northwestern University, NBER, and CEPR
Mathias Trabandt
We extend the canonical epidemiology model to study the interaction between economic
decisions and epidemics. Our model implies that people cut back on consumption and
work to reduce the chances of being infected. These decisions reduce the severity of the
epidemic but exacerbate the size of the associated recession. The competitive equilibrium
is not socially optimal because infected people do not fully internalize the effect of their
economic decisions on the spread of the virus. In our benchmark model, the best simple
containment policy increases the severity of the recession but saves roughly half a million
lives in the United States. (JEL E1, I1, H0)
Received December 19, 2020; editorial decision February 12, 2021 by Editor Ralph Koijen.
We are grateful to Andy Atkeson, Gadi Barlevy, Francisco Ciocchini, Warren Cornwall, Ana Cusolito, João
Guerreiro, Ravi Jaganathan, Aart Kraay, Michael King, Per Krusell, Chuck Manski, Paul Romer, Alp Simsek,
and Steve Strongin for their comments. We thank Bence Bardoczy, Joao Guerreiro, and Laura Murphy for
excellent research assistance. Matlab replication codes can be downloaded from the authors’ websites or directly
from https://tinyurl.com/ERTcode. Send correspondence to Mathias Trabandt, mathias.trabandt@gmail.com.
The Review of Financial Studies 34 (2021) 5149–5187
© The Author(s) 2021. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction
in any medium, provided the original work is properly cited.
doi:10.1093/rfs/hhab040 Advance Access publication August 7, 2021
In this paper, we extend the canonical SIR model proposed by Kermack and
McKendrick (1927) to study the equilibrium interaction between economic
decisions and epidemic dynamics.1 Our model features a two-way interaction
between the epidemic and the economy. People’s decisions to cut back on
consumption and work reduce the severity of the epidemic, as measured by
total deaths. These same decisions exacerbate the size of the recession caused
by the epidemic.
In our model, an epidemic has both aggregate demand and aggregate supply
effects. The supply effect arises because the epidemic exposes workers to the
virus. Workers react to that risk by reducing their labor supply. The demand
effect arises because the epidemic exposes consumers to the virus. Consumers
2 The behavior of susceptible people is also different in the competitive equilibrium and the Pareto optimum. This
difference can also be interpreted as an externality because it influences the dynamics of the epidemic and thus
affects the number of people killed by the virus. See Rachel (2020) and Garibaldi, Espen, and Pissarides (2020)
for a discussion of this effect.
5150
example, if prices are sticky, a given fall in the demand for consumption would
generate a larger recession. Other things equal, a larger recession would mitigate
the spread of the infection.3 But we are confident that the central message from
our current analysis will be robust: there is an inevitable trade-off between the
severity of the recession and the health consequences of the epidemic.4
Our point of departure is the canonical SIR model proposed by Kermack
and McKendrick (1927). In this model, the transition probabilities between
health states are exogenous parameters. We modify the model by assuming
that purchasing consumption goods and working brings people in contact with
each other. These activities raise the probability that the infection spreads. We
refer to the resultant framework as the SIR-macro model.
3 In a follow-up to this paper, Eichenbaum, Rebelo, and Trabandt (2020b) incorporate nominal rigidities and
physical investment into the model.
4 In an interesting essay, Gourinchas (2020) makes a similar point.
5151
In all versions of our model, it is optimal for policy makers to avoid recurrent
epidemics. So a key question for policy is: what is the optimal way to reach
herd immunity?
In the SIR-macro model, it is possible to prevent the infection from spreading
by adopting large, permanent containment measures. This approach has two
problems. First, the permanent containment measures create a persistent
economic depression. Second, the population never reaches herd immunity.
So, infections would recur if containment was ever relaxed.
The best policy in this world is to curtail consumption when externalities
are large, that is, when the number of infected people is high. Such a policy
involves gradually ramping up containment measures as infections rise and
5152
5153
people can work without the risk of becoming infected. The amount that
susceptible and recovered people consume is the same as in the pre-epidemic
steady state. Consumption of infected people depends on whether it is feasible
to deliver goods to them without the risk of infecting other people. In any
event, the economy does not suffer in any meaningful way from a recession.
Moreover, the overall death toll of the epidemic is very small, with the number
of infected people declining monotonically from its initial level to zero.
The previous results point to the importance of antigen and antibody tests
that would allow health care professionals to quickly ascertain people’s health
status. The social returns to gathering this information and acting on it are
enormous. These actions reduce both the death toll and the size of the economic
Here, β ∈ (0,1) denotes the discount factor and ct and nt denote consumption
and hours worked, respectively. For simplicity, we assume that momentary
utility takes the form
θ
u(ct ,nt ) = lnct − n2t .
2
The budget constraint of the representative person is
5154
t = ANt −wt Nt .
μt ct = t .
5 We assume that people know their current health status. In subsequent work (Eichenbaum, Rebelo, and Trabandt
2020a), we develop a model in which people do not know their health status unless they are tested.
5155
6 To simplify, we assume that the probability of a given person being infected through more than one form of
social interactions is zero. In addition, we do not explicitly incorporate the constraint that Tt must be between
zero and the size of population. This constraint is satisfied in all our simulations.
5156
I0 = ε,
S0 = 1−ε.
Everybody is aware of the initial infection and understands the laws of
5157
7 Matlab replication codes can be downloaded from the authors’ websites or directly from
https://tinyurl.com/ERTcode.
5158
πdt = πd +κIt2 ,
where κ > 0. This functional form implies that the case fatality rate is a convex
function of the fraction of the population that becomes infected.8 The basic
SIR-macro model corresponds to the special case of κ = 0.
This expression reflects the fact that with probability δc , this person receives
treatment and becomes recovered.
We now discuss the impact of an effective treatment on population dynamics.
Before the treatment is discovered, population dynamics evolve according to
Equations (1), (2), (3), (4), and (5). Suppose that the treatment is discovered
at the beginning of time t ∗ . Then, all infected people become recovered. The
number of the deceased stabilizes once the treatment arrives, so for t ≥ t ∗ ,
Dt = Dt ∗ .
8 We do not explicitly impose the constraint that π ≤ 1, but this constraint is satisfied in all our simulations.
dt
5159
All infected people are instantly cured. Since no one dies from the disease,
we normalize the number of susceptible people to zero for t > t ∗ . The number
of recovered people is given by
Rt = 1−Dt .
This expression reflects the fact that with probability 1−δv , a person who is
susceptible at time t and did not get infected remains susceptible at time t +1.
With probability δv , this person is vaccinated and becomes immune to the
disease. So, at time t +1, this person’s health situation is identical to that of a
recovered person. The vaccine does not affect the health status of people who
are infected or recovered. The lifetime utilities of infected and recovered people
are given by (10) and (11), respectively.
We now discuss the impact of vaccinations on population dynamics. Before
the vaccine is discovered, these dynamics evolve according to Equations (1),
(2), (3), (4), and (5). Suppose that the vaccine is discovered at the beginning
of time t ∗ . Then, all susceptible people become recovered. Since no one is
susceptible, there are no new infections.
Denote the number of susceptible and recovered people right after a vaccine
is introduced at time t ∗ by St∗ and Rt∗ . The values of these variables are
St∗ = 0
Rt∗ = Rt ∗ +St ∗ .
For t ≥ t ∗ , we have
Rt +πr It for t = t ∗
Rt+1 =
Rt +πr It for t > t ∗ .
The laws of motion for It and Dt are given by (3) and (5).
3. Competitive Equilibrium
In this section, we discuss the properties of the competitive equilibrium via a
series of numerical exercises. In the first subsection, we describe our parameter
5160
values. In the second and third subsections, we discuss how the economy
responds to an epidemic in the SIR and SIR-macro models, respectively. In
the fourth subsection, we discuss the implications of medical preparedness. In
the fifth subsection, we discuss the effects of treatments and vaccines. Finally,
in the sixth subsection, we discuss the robustness of our results.
9 This estimate is roughly eight times greater than the average influenza case fatality rate in the United States.
5161
π1 C 2
= 1/6,
π1 C 2 +π2 N 2 +π3
π2 N 2
= 1/6.
π1 C 2 +π2 N 2 +π3
Here, C and N are consumption and hours worked in the preinfection steady
state. In addition, we assume that at the limit of the simple SIR model, 60%
of the population either recovers from the infection or dies. This assumption
corresponds to the Merkel scenario discussed in the introduction. The implied
values for π1 , π2 , and π3 are 7.8408×10−8 , 1.2442×10−4 , and 0.3901,
respectively.
Our calibration procedure requires various judgment calls. For example, we
had to choose which categories to include in “general community activities.”11
For this reason, we report robustness results below.
The initial population is normalized to one. The number of people who are
initially infected, ε, is 0.001. We choose A = 39.835 and θ = 0.001275 so that
in the pre-epidemic steady state, the representative person works 28 hours per
week and earns a weekly income of $58,000/52. We obtain the per capita
10 We classify the following entries in the ATUS survey as general community activities: purchasing goods and
services; eating and drinking outside the home; organizational, civic, and religious activities; socializing and
communicating; sports, exercise, and recreation; and caring for and helping nonhousehold members.
11 We chose to focus on the connection between market activities and the epidemic. This choice led us to abstract
from the response of nonmarket activities (e.g., “organizational, civic, and religious activities”) to the outbreak
of an epidemic.
5162
income estimate for 2019 from the U.S. Bureau of Economic Analysis and
the average number of hours worked from the Bureau of Labor Statistics 2018
ATUS. We set β = 0.961/52 so that the value of a life is 9.3 million 2019 dollars
in the pre-epidemic steady state. This value is consistent with the economic
value of life used by U.S. government agencies in their decision process.12 We
understand there is considerable uncertainty in the literature about this value.
We find that our conclusions are robust to reasonable perturbations of this value.
We set φ i , the parameter that controls for the relative productivity of infected
people, at 0.8. This value is consistent with the notion that symptomatic people
don’t work and the assumption that 80% of infected people are asymptomatic,
according to the China Center for Disease Control and Prevention. In the
12 See U.S. Environmental Protection Agency (2010) and Moran (2016). See Viscusi and Aldy (2003) for a review
of the literature on the value of a statistical life.
5163
that a given model matches aggregate data on the number of infections and
deaths during an epidemic episode. The implied estimates of R0 depend on the
features of the model, including parametric assumptions. So, reported standard
errors in any given study understate the true uncertainty about R0 .13
We proceed in the spirit of the second method and choose parameters that
imply a value of R0 = 1.45 because they produce plausible implications for the
dynamics of the epidemic. This value is at the low end of available estimates for
R0 but consistent with the evidence taking sampling uncertainty into account
(see, e.g., Riou and Althaus 2020). In Subsection 4.6, we discuss the robustness
of our results to different values of R0 .
13 The difficulty in estimating R is reflected in the broad range of estimates obtained for widely studied diseases,
0
such as measles. The literature on the measles epidemics often cites values of R0 from 12 to 18. In a recent
survey, Guerra et al. (2017) find an even wider range of R0 estimates, from 4 to 60.
5164
% of Initial Population
% of Initial Population
90 50
6
80 40
4 70 30
60 20
2
50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.25 -2 -2
0.2
-4 -4
0.15
-6 -6
0.1
0.05 -8 -8
0 -10 -10
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 1
Basic SIR-Macro Model vs. SIR Model
peak in the SIR model. Eventually, 54% of the population becomes infected. So,
for the United States, roughly 180 million people eventually become infected
and 890,000 people die.
Figure 1 shows that the infection is less severe in the SIR-macro model than
in the SIR model. The reason is that in the SIR-macro model, susceptible people
severely reduce their consumption and hours worked to lower the probability of
being infected. Figure 2 shows that no offsetting effects arise from the behavior
of recovered and infected people because they behave as in the SIR model.
Consistent with these observations, the recession is much more severe in
the SIR-macro model: average aggregate consumption in the first year of the
epidemic falls by 4.7%, a fall seven times larger than in the SIR model.
The dynamics of hours worked are similar in the two models but the
magnitudes are very different.
In the SIR-macro model, hours worked follow a U-shaped pattern. The peak
decline of 9.8% occurs in week 33. Thereafter, aggregate hours rise, converging
to a new steady state from below. These dynamics are driven by the labor
supply decisions of susceptible people. Interestingly, the long-run decline in
hours worked is slightly lower in the SIR-macro model (0.27%) than in the
5165
0 0
-5 -5
% Dev. from Initial Steady State
Hours Susceptibles
-20 -20 Hours Infected
Hours Recovered
0 50 100 0 50 100
Weeks Weeks
Figure 2
Consumption and Hours by Type in Basic SIR-Macro Model
SIR model (0.30%). The reason is that fewer people die in the epidemic, so the
population falls by less in the SIR-macro model than in the SIR model.
Figure 3 shows the competitive equilibrium and the optimal containment
policy in the SIR-macro model. We return to this figure in the next section.
5166
Basic SIR-Macro Model Best Simple Containment Policy Simple Command Containment Policy
% of Initial Population
% of Initial Population
5 90 50
4 80 40
3 70 30
2 60 20
1 50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.3 0 80
% of Initial Population
0.25 -5
60
0.2 -10
%
0.15 -15 40
0.1 -20
20
0.05 -25
0 -30 0
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 3
Basic SIR-Macro Model with and without Containment
dotted red lines virtually coincide. So, in practice, the quantitative effect of
the possibility of treatments on the competitive equilibrium is quite small. As
discussed in Section 5.4, the possibility of treatments does not substantively
affect the design of optimal policy.
Vaccines don’t cure infected people, but they do prevent susceptible people
from becoming infected. So the possibility of future vaccination induces people
to reduce their market activities before the vaccine actually arrives. Given our
calibration, this effect is small in the competitive equilibrium (see the solid blue
and dashed dotted red lines in Figure 6). But, as discussed in Section 5.4, the
possibility of vaccinations substantively affects the design of optimal policy.
It becomes optimal to immediately introduce severe containment measures to
minimize deaths.
3.6 Robustness
Table 1 reports results of a series of robustness exercises in which we vary
key parameters of the basic SIR-macro model. Consider first the parameter
φ i , which controls the productivity of infected workers. The lower is φ i ,
the smaller is the average consumption drop, the peak infection rate, the
cumulative mortality rate, and the total number of U.S. deaths. The behavior
of aggregate consumption reflects two opposing forces. On the one hand, a
lower φ i makes it more costly to become infected. So, susceptible people
5167
% of Ini. Pop.
% of Ini. Pop.
4 80 40
2 60 20
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
% of Ini. St.St.
% of Ini. St.St.
% of Ini. Pop.
-10 -10
0.2
-20 -20
-30 -30
0.8
%
50
0.6
0.4 0
0 50 100 150 0 50 100 150
Weeks Weeks
Figure 4
Medical Preparedness
5168
Basic SIR-Macro Model Model with Treatment Best Simple Containment Policy with Treatment
% of Initial Population
% of Initial Population
5 90 50
4 80 40
3 70 30
2 60 20
1 50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.3 0 80
% of Initial Population
0.25 -5
60
0.2 -10
%
0.15 -15 40
0.1 -20
20
0.05 -25
0 -30 0
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 5
SIR-Macro Model with Treatments
and work to reduce the chances of being infected. Despite the concomitant fall
in peak infection rates, the cumulative mortality rate and the number of U.S.
deaths rise.
Table 1 reports the impact of a change in the medical preparedness parameter,
κ. The lower is κ, the higher is the degree of medical preparedness. We consider
a value of κ = 0.9 such that the case fatality rate in the medical preparedness
model peaks at 1%. Table 1 shows that this higher value of κ is associated with
a more severe recession as people curtail their economic activity in response to
higher case fatality rates. While the peak level of infections falls, the cumulative
death rate and the total number of U.S. deaths rise.
We also assess the impact of reducing the discount factor from 0.961/52 to
0.941/52 . This parameter change reduces the value of a life from 9.3 million to
6.1 million 2019 dollars. As a result, consumption falls less during the epidemic
and infection rates rise. The overall quantitative sensitivity is small.
Overall, Table 1 indicates that the qualitative conclusions of the basic SIR-
macro model are very robust and that the quantitative conclusions are robust to
the perturbations that we consider.
We now discuss the impact of different values of R0 on the properties of our
model. Recall that in the baseline SIR-macro model, R0 is equal to 1.45. Table 2
reports results for alternative values of R0 , ranging from 1.33 to 2.95. Three key
5169
Basic SIR-Macro Model Model with Vaccines Best Simple Containment Policy with Vaccines
% of Initial Population
% of Initial Population
5 90 50
4 80 40
3 70 30
2 60 20
1 50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.3 0 50
% of Initial Population
0.25 40
-5
0.2 30
%
0.15 -10 20
0.1 10
-15
0.05 0
0 -20 -10
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 6
SIR-Macro Model with Vaccines
features emerge from this table. First, high values of R0 generate implausibly
large peak infection rates and mortality rates. Second, high values of R0 imply
that the epidemic runs its course very quickly. For example, for R0 = 2.95,
infections peak in the 13th week of the epidemic. Third, the peak-to-trough
drop in consumption is increasing in R0 . This result reflects people’s response
to the higher probability of becoming infected. Interestingly, the average drop
in consumption over the first year of the epidemic is not very sensitive to R0 .
This property results from two effects. The first effect is a much larger peak-
to-trough drop in consumption for high values of R0 . The second effect is a
shorter epidemic, and a shorter recession, for high values of R0 . For example,
for R0 = 2.95, consumption initially drops precipitously but recovers after 13
weeks as infections wane.
In sum, Table 2 shows that the qualitative features of our model are very
robust to different values of R0 . But the quantitative properties of the model
do depend on R0 . As we discuss above, much of the evidence on R0 in the
literature is model based. Viewed through the lens of our model, the most
plausible value of R0 is relatively low, around 1.5, a value that is consistent
with the literature taking sampling uncertainty into account. If one insists on
calibrating the model with a high value of R0 , then the model must be extended
to make it consistent with the data.
5170
Table 1
Robustness in basic SIR-macro model without containmenta
Consumption Infection rate Mortality rate U.S. deaths
%b %c %d millionse
a See Section 3.6 for a discussion of the results provided in this table.
b Average drop in consumption in first year relative to preinfection steady state.
c Peak infection rate relative to pre-epidemic population.
d Cumulative mortality rate at the end of the epidemic.
e Total number of deaths in the United States at the end of the epidemic.
Table 2
Robustness in basic SIR-macro model without containment with respect to R0 a
Pop. Cons. Inf. Mort. U.S. Time to
infected Cons. trough rate rate deaths peak infection
%b R0 %c %d %e %f millionsg weekh
5171
4. Economic Policy
The competitive equilibrium of our model economy is not Pareto optimal. A
classic externality is associated with the behavior of infected people. Because
each person is atomistic, people don’t take into account the impact of their
actions on the infection and death rates of other people. But collectively, the
behavior of infected people imposes an unpriced cost on susceptible people.
In this section, we consider a simple Ramsey problem designed to deal with
this externality. As it turns out, the solution to the Ramsey problem is quite
similar to the solution of a planner’s problem in which the planner chooses
consumption and labor subject to the constraint that these choices are the same
for everybody regardless of health status.
5172
5173
A similar conclusion holds for optimal policy in the benchmark SIR model
discussed below.14
14 Both the peak in infections and the fall in aggregate consumption are slightly larger under simple command
containment than under simple containment. This result reflects compositional effects. First, the consumption
of recovered people drops by more under simple command containment because everybody must have the
same consumption. Second, the consumption of infected people is substantially lower under simple containment
than under simple command containment. This property reflects infected people’s lower productivity and their
response to the Pigouvian tax. Third, the consumption of susceptible people is similar under both policies. The net
effect is that, even though aggregate consumption drops by more under simple command containment, infection
rates are higher, reflecting the higher consumption of infected people.
5174
arrive. Compared to the competitive equilibrium (dashed dotted red lines), the
peak of the infection rate drops from 5.3% to 3.3% of the initial population.
Moreover, the infection peak occurs in week 42 rather than in week 33. Absent
a vaccine being discovered, the optimal containment policy reduces the death
toll as a percentage of the initial population from 0.27% to 0.24%. For the
United States, this reduction amounts to about 100,000 lives. It is important to
remember that this reduction pertains to a worst-case scenario in which vaccines
do not arrive.
Above, we discuss why it is not optimal to introduce immediate containment
measures in the basic SIR-macro and treatment models. But why is the optimal
policy so different in the vaccination model? The basic reason is that, unlike
5175
5176
Benchmark SIR-Macro Model Best Simple Containment Policy Simple Command Containment Policy
90 50
% of Initial Population
% of Initial Population
% of Initial Population
4
80 40
3
70 30
2
60 20
1 50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.4 0 80
-5
% of Initial Population
60
0.3
-10
40
%
0.2 -15
20
-20
0.1
-25 0
0 -30 -20
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 7
Benchmark SIR-Macro Model (Vaccines, Treatment, Med. Preparedness)
5177
Best Simple Containment Policy in Benchmark Model Early Exit from Best Simple Containment Policy
4 -5 60
0.3
3 -10
40
0.2 -15
2
-20 20
0.1
1
-25
0
0 0 -30
0 50 100 0 50 100 0 50 100 0 50 100
4 -5 60
0.3
3 -10
40
0.2 -15
2
-20 20
0.1
1
-25
0
0 0 -30
0 50 100 0 50 100 0 50 100 0 50 100
Figure 8
Benchmark SIR-Macro Model (Vaccines, Treatment, Med. Preparedness)
5178
Benchmark SIR-Macro Model Best Simple Containment Policy Late Start of Best Simple Containment Policy (Week 33)
90 50
% of Initial Population
% of Initial Population
% of Initial Population
4
80 40
3
70 30
2
60 20
1 50 10
0 40 0
0 50 100 150 0 50 100 150 0 50 100 150
0.4 0 250
0.3
-20 150
%
0.2 -30 100
-40 50
0.1
-50 0
0 -60 -50
0 50 100 150 0 50 100 150 0 50 100 150
Weeks Weeks Weeks
Figure 9
Benchmark SIR-Macro Model (Vaccines, Treatment, Med. Preparedness)
the expressions for the lifetime utility of the different people, the transmission
function (1), and the laws of motion for the population, (2), (3), (4), and (5).
The lifetime utilities of susceptible, infected and recovered people are
given by
Uti = u(Cti ,Nti )+(1−δc ) (1−πr −πdt )βUt+1
i r
+πr βUt+1 r
+βδc Ut+1 ,
5179
Infected, I Susceptibles, S
0.12 100
0.1
% of Initial Population
% of Initial Population
99
0.08
98
0.06
97
0.04
96
0.02
0 95
0 100 200 300 400 500 0 100 200 300 400 500
0.02
-0.04
0.015
-0.06
0.01
-0.08
0.005
-0.1
0 -0.12
0 100 200 300 400 500 0 100 200 300 400 500
Weeks Weeks
Figure 10
Smart Containment in the Benchmark SIR-Macro Model
−∞. But the closer the consumption of those infected is to zero, the higher
is social welfare. Because infected people are completely isolated, the initial
infection quickly dies out without causing a recession.
The previous analysis assumes that infected people have to be in contact
with other people to obtain consumption goods. This assumption underlies the
draconian policy implication that the consumption of infected people should
be kept at a minimum. Suppose instead that the planner can directly deliver
consumption goods to the infected so they do not need to go shopping. The
solution to this modified problem continues to have the property that infected
people don’t work. But they consume the same as other people. Since there is
such a small number of infected people at time zero, aggregate consumption
and hours worked are essentially the same as in the pre-epidemic steady state.
One important limitation of smart containment is that herd immunity is never
reached. Every infection case must be detected and dealt with until the virus
is extinguished. Otherwise, the epidemic would begin anew as soon as smart
containment ended.
Our simple analysis of smart containment assumes that policy makers
know the health status of different individuals. In reality, this knowledge
would require antigen and antibody tests for immunity and infection that are
sufficiently accurate to act on. Our results suggest enormous social returns to
5180
having these tests and the policy instruments to implement smart containment.15
This conclusion is consistent with the importance of early detection and early
response emphasized by epidemiologists, such as Ginsberg et al. (2008). In
a subsequent paper, Eichenbaum, Rebelo, and Trabandt (2020a) study the
efficacy of smart containment policies in a setting in which people do not
know their health status until they are tested.
15 According to de Walque, Friedman, and Mattoo (2020), the average cost per test, including equipment,
consumables, protective equipment, and labor, ranges from $2 to $5.
5181
total death toll will reach 630,000 by June 2021. This forecast lies within the
range of the model’s predictions although somewhat at the lower end, reflecting
in part the expected positive impact of the ongoing vaccination campaign.
An important failing of the model has to do with the timing of these deaths.
In the data, a significant second wave of deaths took place between December
2020 and February 2021. Our model generates a second wave if we assume
that containment ended prematurely (see Figure 8). But the magnitude of that
wave is much smaller than that observed in the data. We do not think that this
failing reflects the calibration that we used. Consistent with Atkeson (2021),
we conjecture that a combination of seasonality in the transmission rate and
changes in the way people react to infection risk are likely to be important
7. Related Literature
Our work is related to a pre-Covid literature that combines economics and
epidemiology (for a review, see Perrings et al. 2014). Examples include analyses
of how private vaccination incentives affect epidemic dynamics and optimal
public health policy (e.g., Philipson 2000; Manski 2010; Adda 2016) and studies
of the interaction between behavioral choice and the dynamics of the HIV/AIDS
epidemic (e.g., Kremer 1996; Greenwood et al. 2019).
The COVID-19 crisis has stimulated a rapidly growing body of work on the
economics of the epidemic. Below, we briefly summarize the first wave of this
research program.
Atkeson (2020) provides an overview of SIR models and explores their
implications for the COVID-19 epidemic. Alvarez, Argente, and Lippi (2020)
study the optimal lockdown policy in a version of the canonical SIR model
in which the case fatality rate increases with the number of infected people.
Toxvaerd (2020) analyses the equilibrium amount of social distancing in a SIR
model and argues that it is not socially optimal.
Jones, Philippon, and Venkateswaran (2021) study optimal mitigation
policies in a model in which economic activity and epidemic dynamics interact.
These authors emphasize learning-by-doing in working from home and assume
that people have a fatalism bias about the probability of being infected in the
future. Other differences between our paper and theirs are as follows. First, we
explicitly allow for the probabilistic arrival of vaccines and treatments. Second,
we consider the social cost of starting containment too late or ending it too early.
5182
8. Conclusion
We extend the canonical epidemiology model to study the interaction between
economic decisions and epidemics. In our model, the epidemic generates both
supply and demand effects on economic activity. These effects work in tandem
to generate a large, persistent recession.
We abstract from many important real-world complications to highlight the
basic economic forces at work during an epidemic. The central message of
our analysis should be robust to allowing for those complications: there is an
inevitable trade-off between the severity of the short-run recession caused by
the epidemic and the health consequences of that epidemic. Dealing with this
trade-off is a key challenge confronting policy makers.
Our model also abstracts from various forces that might affect the long-
run performance of the economy. These forces include bankruptcy costs,
unemployment hysteresis effects, and the destruction of supply chains. It is
important to embody these forces in macroeconomic models of epidemics and
study their positive and normative implications.
5183
θ nrt = Aλrbt ,
r −1
ct = (1+μt )λrbt ,
θ r 2
urt = lnctr − n .
θ nit = φ i Aλibt ,
i −1 i
ct = λbt ,
θ i 2
uit = lncti − n ,
2 t
(1+μt )cts = Anst +t ,
θ s 2
ust = lncts − n .
2 t
Given initial values for Pop0 , S0 , I0 , R0 , and D0 , iterate forward using the following seven equations
for t = 0,..,H −1:
Tt = π1 (St cts ) It cti +π2 (St nst ) It nit +π3 St It ,
St+1 = St −Tt ,
Rt+1 = Rt +πr It ,
πdt = πd +κIt2 ,
Dt+1 = Dt +πdt It .
Iterate backward from the post-epidemic steady-state values of Uts and Uti :
Uti = u(cti ,nit )+(1−δc ) (1−πr −πdt )βUt+1
i r
+πr βUt+1 r
+βδc Ut+1 .
Tt
τt = ,
St
5184
References
Adda, J. 2016. Economic activity and the spread of viral diseases: Evidence from high frequency data. Quarterly
Journal of Economics 131:891–941.
Alvarez, F., D. Argente, and F. Lippi. 2021. A simple planning problem for COVID-19 lockdown, testing, and
tracing. American Economic Review: Insights. Advance Access published 10.1257/aeri.20200201.
Atkeson, A. 2020. What will be the economic impact of COVID-19 in the US? Rough estimates of disease
scenarios. Working Paper No. w26867, National Bureau of Economic Research.
———. 2021. A parsimonious behavioral SEIR model of the 2020 COVID epidemic in the United States and
the United Kingdom. Working Paper No. w28434, National Bureau of Economic Research.
Atkeson, A., K. Kopecky and T. Zha. 2020. Behavior and the Transmission of COVID-19. Working Paper,
University of California, Los Angeles.
Bennhold, K., and M. Eddy. 2020 Merkel gives Germans a hard truth about the coronavirus. New York Times,
March 11.
Berger, D., K. Herkenhoff, C. Huang, and S. Mongey. 2020. Testing and reopening in an SEIR model. Review of
Economic Dynamics. Advance Access published November 27, 2020, 10.1016/j.red.2020.11.003.
Bootsma, M., and N. Ferguson. 2007. The effect of public health measures on the 1918 Influenza pandemic in
US cities. Proceedings of the National Academy of Sciences 104:7588–93.
Bernanke, B., and J. Yellen (2020) The Federal Reserve must reduce long-term damage from coronavirus.
Financial Times, March 18.
Breban, R., R. Vardavas, and S. Blower. 2007. Theory versus data: How to calculate R0? PLoS One 2:e282.
Buera, F., R. Fattal-Jaef, P. Neumeyer, and Yongseok Shin. 2020. The economic ripple effects of COVID-19.
Working Paper, World Bank.
Chetty, R., J. Friedman, N- Hendren, M. Stepner, and the Opportunity Insights Team. 2020. How did COVID-19
and stabilization policies affect spending and employment? A new real-time economic tracker based on private
sector data. Working Paper, Harvard University.
de Walque, D., J. Friedman and A. Mattoo. 2020. Two tests for a COVID-19 world. Working Paper, World Bank.
5185
Eichenbaum, M. S., S. Rebelo, and M. Trabandt. 2020a. The macroeconomics of testing and quarantining.
Working Paper No. w27104 National Bureau of Economic Research.
———. 2020b. Epidemics in the neoclassical and new Keynesian models. Working Paper No. w27430. National
Bureau of Economic Research.
Eichenbaum, M. S., M. Godinho de Matos, F. Lima, S. Rebelo, and M. Trabandt. 2020. How do people respond
to small probability events with large, negative consequences? Working Paper No. w27988, National Bureau of
Economic Research.
Farboodi, M., G. Jarosch and R. Shimer, 2020. Internal and external effects of social distancing in a pandemic.
Working Paper, University of Chicago, Becker Friedman Institute for Economics.
Farhi, E. and I. Werning. 2020. Dealing with the trilemma: Optimal capital controls with fixed exchange rates.
Working Paper, Harvard University.
Faria-e-Castro, M. Forthcoming. Fiscal policy during a pandemic. Journal of Economic Dynamics and Control.
Garibaldi, P., E. Moen, and C. Pissarides. 2020. Modeling contacts and transitions in the SIR epidemics model.
Working Paper, London School of Economics.
Ginsberg, J., M. Mohebbi, R. Patel, L. Brammer, M. Smolinski, and L. Brilliant. 2008. Detecting Influenza
epidemics using search engine query data. Working Paper, Centers for Disease Control and Prevention.
Gourinchas, P. 2020. Flattening the pandemic and recession curves. Working Paper, University of California,
Berkeley.
Glover, A., J. Heathcote, D. Krueger, and J. Ríos-Rull. 2020. Health versus wealth: On the distribution effects
of controlling a pandemic. Working Paper, University of Pennsylvania.
Goolsbee, A., and C. Syverson. 2021. Fear, lockdown, and diversion: Comparing drivers of pandemic economic
decline. Journal of Public Economics 193:10.1016/j.jpubeco.2020.104311.
Greenwood, J., P. Kircher, C. Santos, and M. Tertilt. 2019. An equilibrium model of the African HIV/AIDS
epidemic. Econometrica. 87:1081–113.
Guerra, F., S. Bolotin, G. Lim, J. Heffernan, S. Deeks, Y. Li, and N. Crowcroft. 2017. The basic reproduction
number (R0) of measles: A systematic review. Lancet Infectious Diseases 17:e420–e428.
Guerrieri, V., G. Lorenzoni, L. Straub, and I. Werning. 2020. Macroeconomic implications of COVID-19: Can
negative supply shocks cause demand shortages? Working Paper, University of Chicago.
Hatchett, R., C. Mecher, and M. Lipsitch. Public health interventions and epidemic intensity during the 1918
Influenza pandemic. Proceedings of the National Academy of Sciences 104:7582–7.
Jones, C., T. Philippon, and V. Venkateswaran. 2021. Optimal mitigation policies in a pandemic: Social Distancing
and Working from Home. Review of Financial Studies 34:5188–224.
Kaplan, G., B. Moll, and G. Violante. 2020. The great lockdown and the big stimulus: Tracing the pandemic
possibility frontier for the US. Working Paper, University of Chicago.
Kermack, W., and A. McKendrick. 1927. A contribution to the mathematical theory of epidemics. Proceedings
of the Royal Society of London, series A 115:700–721.
Kremer, M. 1996. Integrating behavioral choice into epidemiological models of AIDS. Quarterly Journal of
Economics 111:549–73.
5186
Krueger, D., H. Uhlig, and T. Xie. 2020. Macroeconomic dynamics and reallocation in an epidemic. Working
Paper, University of Pennsylvania.
Lee, B., S. Brown, P. Cooley, R. Zimmerman, W. Wheaton, S. Zimmer, and J. Grefenstette. 2010. A computer
simulation of employee vaccination to mitigate an influenza epidemic. American Journal of Preventive Medicine
38:247–57.
Manski, C. 2010. Vaccination with partial knowledge of external effectiveness. Proceedings of the National
Academy of Sciences 107:3953–60.
Moran, M. 2016. Guidance on treatment of the economic value of a statistical life in U.S. Department of
Transportation Analyses. 2014 Adjustment. Report, U.S. Department of Transportation.
Pueyo, T. 2020. Coronavirus: Why you must act now. Politicians, community leaders and business leaders: What
should you do and when? Medium, March 10.
Rachel, L. 2020. An analytical model of Covid-19 lockdowns. Working Paper, Bank of England.
Riou, J., and C. Althaus. 2020. Pattern of early human-to-human transmission of Wuhan. Eurosurveillance
25:10.2807/1560-7917.ES.2020.25.4.2000058.
Salje, H., C. Tran Kiem, N. Lefrancq, N. Courtejoie, P. Bosetti, J. Paireau, and A. Andronico. 2020. Estimating
the burden of SARS-CoV-2 in France. Science 369:208–11.
Stock, J. 2020. Coronavirus data gaps and the policy response to the novel coronavirus. Working Paper, Harvard
University.
Villas-Boas, S., J. Sears, M. Villas-Boas, and V. Villas-Boas. 2020. Are we staying home to flatten the curve?
Working Paper, University of Berkeley.
Viscusi, W., and J. Aldy. 2003. The value of a statistical life: A critical review of market estimates throughout
the world. Journal of Risk and Uncertainty 27:5–76.
U.S. Environmental Protection Agency. Valuing mortality risk reductions for environmental policy. White Paper.
5187